Protean is currently running the following clinical trials, with the goal of improving testing for cancer patients.
Liquid Biopsy Trial for Metastatic Breast Cancer
– Trial Currently on Hold
This is a clinical trial evaluating the accuracy of a blood test, to replace a tissue biopsy in women with recurrent metastatic breast cancer. The goal is to validate the use of blood tests to guide breast cancer therapy.
Liquid Biopsy Trial for Lung and Melanoma Cancer
This is a liquid biopsy study, evaluating the accuracy of blood proteomic analysis to predict cancer response to immunotherapy. The goal is to develop blood tests that will more accurately predict if a patient with lung cancer or advanced melanoma will respond to potentially toxic and costly immunotherapy treatments.
For more information on our clinical trials, please contact our research manager Hannah Park :
Email: hannah.park@proteanbiodx.com
